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ABSTRACT Coronaviruses contain a small envelopemembraneproteinwith cation-selective ion channel activitymediated by its
transmembrane domain (ETM). In a computational study, we proposed that ion channel activity can be explained by either of two
similar ETM homopentameric transmembrane a-helical bundles, related by a ;50 rotation of the helices. Later, we tested this
prediction, using site-speciﬁc infrared dichroism of a lysine-ﬂanked isotopically labeled ETM peptide from the virus responsible for
the severe acute respiratory syndrome, SARS, reconstituted in lipid bilayers. However, the data were consistent with the presence
of a kink at the center of theETMa-helix, and it did not ﬁt completely either computationalmodel. Herein, we have usednativeETM,
without ﬂanking lysines, and show that the helix orientation is now consistent with one of the predictedmodels. ETMonly produced
one oligomeric form, pentamers, in the lipid-mimic detergent dodecylphosphocholine and in perﬂuorooctanoic acid.We thus report
the correct backbonemodel for the pentamerica-helical bundle of ETM. The disruptive effects caused by terminal lysines probably
highlight the conformational ﬂexibility required during ion channel function.
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Coronaviruses are enveloped viruses responsible for a
variety of acute and chronic diseases (1). Their members have
an envelope (E) protein, embedded in the membrane, which
is critical for virion morphogenesis (2,3). These E proteins
have also shown cation-selective ion channel activity, not
only in the virus causative of severe acute respiratory syn-
drome (SARS), but also in other members of the coronavirus
genus (4,5). Ion channel activity is inhibited by the drug
hexamethylene amiloride (HMA) in murine hepatitis virus
and in human coronavirus 229E, and this inhibition was
correlated with decreased viral replication in these viruses.
Also, HMA did not have antiviral activity against a recom-
binant murine hepatitis virus where E protein had been
deleted (5), pointing to coronavirus E proteins as a pharma-
cological target.
In severe acute respiratory syndrome (SARS), the E
protein has 76 amino acids, and contains one transmembrane
a-helical domain (ETM), which is responsible for the
observed ion channel activity (4,6) via the likely formation
of a transmembrane a-helical bundle. In a recent computa-
tional work (7), we suggested possible models for ETM
oligomerization by exploring exhaustively the conforma-
tional space of several ETM oligomers (8). This search was
run in parallel with homologous sequences of ETM present
in other coronaviruses, on the assumption that they share a
common backbone structure (9). Conservative mutations that
appear during evolution act as a ﬁlter, destabilizing nonna-
tive models. At the same time, these mutations leave
unaffected those models representing the native backbone
structure. Under these evolutionary constraints, only two
models compatible with ion channel activity were found,
both pentameric, referred to as models A and B (7). These
two models had the same handedness and similar helix tilt,
and were related by a ;50 rotation of their a-helices (7)
(see Table 1, Models A and B). In 14 out of 15 ETM homol-
ogous sequences, lowest-energy models clustered around
model A (11), which was therefore likely to represent the
native backbone structure of the ETM ion channel.
To test our computational prediction, we performed
recently a site-speciﬁc infrared dichroism study (12) of
ETM in the SARS E sequence, reconstituted in dimyristoyl-
phosphatidylcholine lipid bilayers. ETM was isotopically-
labeled with 13C¼18O (10), at nine native residues, except at
F-23, where we used Ala because of the lack of labeled Phe.
In addition, to facilitate puriﬁcation (13), ETM was ﬂanked
by two lysines at each N- and C termini (K2-ETM-K2), as it
has been shown for various a-TM oligomers that even four
ﬂanking lysines at each C- and N-terminus do not affect
oligomerization during SDS-PAGE (14,15). Although the
rotational orientation (12), v, of the centrally located labels
was consistent with one of the models (B), labels located at
the N- and C-ends of the TM were consistent with model A
(10), suggesting a mild twist, or kink, in a region of the helix
near residue F-23 (see Table 1, column K2-ETM-K2 (A-23)).
To test the possible effect of the mutation F-23A on ETM
structure, we have studied herein the same peptide, K2-ETM-
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K2, but using the native F-23 residue isotopically labeled
with 13C¼18O. We note that the use of label F-23, instead of
A-23, should not only affect the v value at F-23, but also the
calculated value for the preceding and following residue.
Indeed, the rotational orientation, v, is calculated by
combining two consecutive residues (12), which are as-
sumed to be separated by Dv¼ 100 for canonical a-helices.
The infrared spectra obtained for K2-ETM-K2 were similar to
those obtained previously (10), and are not shown.
Thus, from the measured dichroic ratios of the K2-ETM-
K2 sample, Rhelix and Rsite (shown in the Supplementary
Material, Table 1, Data S1), we recalculated the orientational
data for the labeled residues 22 and 24 (10). Table 1 (column
K2-ETM-K2 (F-23)) shows that the recalculated v values are
still incompatible with either model A or B.
Next, to test the effect of terminal lysine residues on ETM
structure, we used the SARS ETM peptides shown in Fig. 1,
where terminal lysines have been substituted to native ETM
residues. These peptides were labeled independently at ﬁve
native consecutive residues: L-21, A-22, F-23, V-24, and V-25.
The data were analyzed as above (dichroisms are shown in
the Supplementary Material, Table 1, Data S1), and the cal-
culated v values are indicated in the last column of Table
1 (ETM). These values are clearly consistent with model A;
therefore, we conclude that the presence of terminal lysines in
K2-ETM-K2 introduces a perturbation in the ETM structure,
at least from residues 19 to 24. Consistent with this, solution
NMR results of ETM in dodecylphosphocholine (DPC)
micelles also indicate a kink in the central part of the a-helix
in the peptideK2-ETM-K2, but not in ETM (Fig. S1,Data S1).
To conﬁrm that ETM forms pentamers, we performed a
sedimentation equilibrium study in DPC micelles. DPC is a
mimic for dimyristoylphosphatidylcholine, as it has the same
polar headgroups, and has been routinely used to determine
oligomeric size of TM a-helices, e.g., (16). The sedimen-
tation data could be best ﬁtted to a monomer-pentamer self-
association model, with an association constant of 17.1 (Fig.
S2, Data S1), although a higher order aggregate (n. 10) was
also present (;10% of the material) at high concentrations of
the peptide (not shown).
We also performed electrophoresis of ETM in the mild
detergent perﬂuorooctanoic acid (PFO). Although less
suitable than zwitterionic DPC, this detergent has been
successfully used to determine the oligomeric sizes of a-helical
transmembrane peptides, e.g., in the tetrameric phospholem-
man (17), or the pentameric small hydrophobic protein in
the respiratory syncytial virus (18), which in SDS produced
either monomers or multiple nonspeciﬁc oligomers, re-
spectively. Fig. 2 shows that the only oligomer of ETM in
PFO is pentameric (lane 3). By contrast, in K2-ETM-K2
(lane 2), the pentamer was not stable, and only produced
dimers and trimers. Results in SDS were identical as those
described previously (6,7,10) and are shown in Fig. S4
(Data S1).
These results suggest that the terminal lysines in K2-ETM-
K2 not only induce a kink in the ETM a-helix, but also may
weaken interhelical interactions. These two effects, however,
do not inactivate the ETM ion channel present in lipid
bilayers, because K2-ETM-K2 shows sodium ((6) and Fig.
S5, Data S1) conductance activity, which was blocked by
amantadine (6). ETM, however, displayed a different
FIGURE 1 Synthetic peptide sequences of SARS ETM, with
isotopically (13C518O) labeled residues indicated in bold, used
for site-speciﬁc infrared dichroism. N- and C-terminal lysines
used in a previous work (10) have been changed to the residues
underlined, which correspond to native SARS ETM residues.
TABLE 1
Residue Model A Model B
K2-ETM-K2
(A-23)
K2-ETM-K2
(F-23) ETM
V-17 31 80 47 6 5
L-18 57 8 15 6 8
L-19 164 110 105 6 3
F-20 78 132
L-21 6 30 44 6 4 4 6 4
A-22 106 60 50 6 7 22 6 7 113 6 8
F-23 128 183 170 6 7 76 6 7 109 6 7
V-24 32 83 70 6 4 24 6 4 6 6 5
V-25 80 22 94 6 5
F-26 173 130
L-27 64 113 48 6 4
L-28 22 15 52
Rotational orientation values, v, for the predicted pentameric models A and
B (7), experimental values from K2-ETM-K2 using label A-23 (10), from
K2-ETM-K2 using native label F23 (this work), and native ETM without
ﬂanking lysines (this work). The helix tilt for the last two columns was 20–
25 and is not shown.
FIGURE 2 Electrophoresis of ETM in PFO. Lane 1, molecular
weight markers; lane 2, K2-ETM-K2; and lane 3, ETM without
lysines(see Fig. 1). Arrows indicate monomers, dimers, and
trimers (lane 2), and monomers and pentamers (lane 3).
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conductance behavior relative to K2-ETM-K2, with an open
probability that was proportional to the potential (Fig. S5,
panel d, Data S1). By contrast, in K2-ETM-K2, this depen-
dency was lost. In addition, amantadine was less effective as
an inhibitor for ETM than for K2-ETM-K2 (Fig. S6, Data S1).
Overall, our results show that ﬂanking lysines induce a
kink in ETM and weaken interhelical interactions. The
precise origin of these effects is unknown, but it is likely
related to the interaction of lysine side chains with the
phosphocholine interface headgroups. These effects may
unveil the presence of inherent conformational plasticity in
ETM, possibly required during ion channel function, as
suggested for other ion channels (19,20). Indeed, the central
region of ETM, i.e., two turns from residue 19 to 26, contains
three phenylalanines (bulky) and two valines (b-branched),
which are known to destabilize a-helices (21).
Our previous results (6) indicate that amantadine has more
afﬁnity for this lysine-induced conformational state than for
the model represented by the native ETM, model A (10).
This could explain the observed lack of protection of
amantadine against SARS-induced cytopathic effects (22). A
more detailed NMR study of the structure of this channel,
complexed with the inhibitory drug HMA, is under way.
SUPPLEMENTARY MATERIAL
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